Atlas Trials

Open-Label Extension Study of MHB018A in Patients With Thyroid Eye Disease

Clinical trial NCT07620405 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07620405
Sponsor
Minghui Pharmaceutical (Hangzhou) Ltd
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Thyroid Eye Disease (TED)
Start date
2027-07-01
Primary completion
2030-01-01
Enrollment
219

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.